ATYR
aTyr Pharma
ATYR
ATYR
111 hedge funds and large institutions have $43.7M invested in aTyr Pharma in 2026 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 30
22% less capital invested
Capital invested by funds: $55.7M → $43.7M (-$12M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
111
Holding in Top 10
–
Calls
$766K
Puts
$280K
Top Buyers
| 1 | +$1.89M | |
| 2 | +$1.39M | |
| 3 | +$583K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$149K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$117K |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$799K | |
| 3 | -$361K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$231K |
| 5 |
Morgan Stanley
New York
|
-$150K |
